Digital mammography alliance goes through
Hologic and Agfa have finalized an agreement under which Hologic will manufacture a digital mammography system to be private-labeled and distributed by Agfa in certain international markets. The system, which Agfa will call Embrace, will be built around
Hologic and Agfa have finalized an agreement under which Hologic will manufacture a digital mammography system to be private-labeled and distributed by Agfa in certain international markets. The system, which Agfa will call Embrace, will be built around Hologic's flat-panel amorphous selenium technology but will include Agfa image processing and information technology. The Joint Development and OEM Purchase Agreement is an outgrowth of a Letter of Intent signed by the two companies in April 2002.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
